[HTML][HTML] Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir
Cytomegalovirus (CMV) infections may increase morbidity and mortality in
immunocompromised patients. Until recently, standard antiviral drugs against CMV were …
immunocompromised patients. Until recently, standard antiviral drugs against CMV were …
[HTML][HTML] Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection
E Faure, T Galperine, O Cannesson, S Alain… - Medicine, 2016 - journals.lww.com
Interventions: Both patients received brincidofovir for the treatment of cytomegalovirus
infection with mutation of UL-97. They presented an acute kidney injury without any …
infection with mutation of UL-97. They presented an acute kidney injury without any …
Cytomegalovirus in hematopoietic stem cell transplant recipients: prevention, diagnosis, and treatment
JF Camargo - Emerging transplant infections: clinical challenges and …, 2021 - Springer
Human herpesvirus 5, better known as cytomegalovirus (CMV), infects 50–90% of the adult
population worldwide and is the most common opportunistic infection in allogeneic …
population worldwide and is the most common opportunistic infection in allogeneic …
In-depth summary over cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation recipients
S Karami, E Roshandel, H Ghaffari Nazari, A Hajifathali… - Virusdisease, 2021 - Springer
In this study, we reviewed various aspects of cytomegalovirus infection, including
pathophysiology, diagnosis methods, and antiviral treatments. Background: Infections …
pathophysiology, diagnosis methods, and antiviral treatments. Background: Infections …
Antiviral drugs
S Othumpangat, SD Ray, JD Noti - Side Effects of Drugs Annual, 2017 - Elsevier
Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse
effects of drugs and adverse reactions to them are surveyed. This review of the January …
effects of drugs and adverse reactions to them are surveyed. This review of the January …
Developing a Novel Gold Nanoparticle-based Colorimetric Assay for the Detection of Cytomegalovirus (CMV) in Pediatric-derived Urine Specimens
S Gupta - 2024 - stars.library.ucf.edu
Cytomegalovirus (CMV) is a member of the Herpesviridae family and is known to infect
people of all ages. In most cases, CMV infection is asymptomatic, and the virus is cleared …
people of all ages. In most cases, CMV infection is asymptomatic, and the virus is cleared …
Nouvelles approches dans la prise en charge de l'infection congénitale à cytomégalovirus: du dépistage au traitement
P Coste Mazeau - 2023 - theses.fr
Résumé L'infection congénitale à cytomégalovirus (CMV) est la plus fréquente des
infections congénitales et la première cause de handicap neurosensoriel d'origine …
infections congénitales et la première cause de handicap neurosensoriel d'origine …
[HTML][HTML] Цитомегаловирусная инфекция после трансплантации почки: реальные достижения и перспективы изучения патогенеза, профилактики и лечения
ЕИ Прокопенко - Вестник трансплантологии и искусственных …, 2019 - journal.transpl.ru
Аннотация Цитомегаловирусная (ЦМВ) инфекция играет важную роль в клинической
трансплантологии, поскольку повышает риск развития осложнений, потери …
трансплантологии, поскольку повышает риск развития осложнений, потери …
Nouvelles approches dans la prise en charge de l'infection congénitale à cytomégalovirus: du dépistage au traitement
PC Mazeau - 2023 - theses.hal.science
L'infection congénitale à cytomégalovirus (CMV) est la plus fréquente des infections
congénitales et la première cause de handicap neurosensoriel d'origine infectieuse chez les …
congénitales et la première cause de handicap neurosensoriel d'origine infectieuse chez les …
[PDF][PDF] Identification of antiviral compounds against equid herpesvirus-1 using real-time cell assay screening: Efficacy of decitabine and valganciclovir alone or in …
C Thieulent, E Hue, G Sutton, C Fortier… - 2021 - hal-normandie-univ.archives …
Despite preventive treatments with vaccines, resurgence of EHV-1 infection still constitutes a
major threat to equine industry. However, no antiviral compound is available to treat infected …
major threat to equine industry. However, no antiviral compound is available to treat infected …